These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36894588)

  • 1. A comparative analysis of clinicopathological features and survival between pre and postmenopausal breast cancer from an Indian cohort.
    Nimbalkar VP; Rajarajan S; V P S; Alexander A; Kaluve R; Selvam S; Ramesh R; B S S; Prabhu JS
    Sci Rep; 2023 Mar; 13(1):3938. PubMed ID: 36894588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
    Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
    Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
    Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
    Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer.
    Ochi T; Bianchini G; Ando M; Nozaki F; Kobayashi D; Criscitiello C; Curigliano G; Iwamoto T; Niikura N; Takei H; Yoshida A; Takei J; Suzuki K; Yamauchi H; Hayashi N
    Eur J Cancer; 2019 Sep; 118():41-48. PubMed ID: 31302586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center study.
    von Au A; Klotzbuecher M; Uhlmann L; Boudewijns M; Michel L; Wallwiener M; Heil J; Golatta M; Rom J; Sohn C; Schneeweiss A; Schuetz F; Domschke C
    Arch Gynecol Obstet; 2017 Apr; 295(4):971-978. PubMed ID: 28176013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis.
    Lohmann AE; Soldera SV; Pimentel I; Ribnikar D; Ennis M; Amir E; Goodwin PJ
    J Natl Cancer Inst; 2021 Nov; 113(11):1465-1475. PubMed ID: 33620467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
    Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
    World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of breast cancer subtypes in elderly patients.
    Bergen ES; Tichy C; Berghoff AS; Rudas M; Dubsky P; Bago-Horvath Z; Mader RM; Exner R; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
    Breast Cancer Res Treat; 2016 May; 157(1):91-9. PubMed ID: 27107570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
    Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
    Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer.
    Zenan H; Zixiong L; Zhicheng Y; Mei H; Xiongbin Y; Tiantian W; Min D; Renbin L; Changchang J
    J Cell Physiol; 2019 Nov; 234(11):20584-20602. PubMed ID: 31016756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of breast cancer characteristics in young premenopausal and postmenopausal women in Ghana.
    Bosompem K; Yorke J; Buckman TA; Brenu SG; Nyantakyi M; Aitpillah FS; Kyei I; Adinku MO; Yorke DA; Obirikorang C; Acheampong E
    Sci Rep; 2024 Feb; 14(1):2704. PubMed ID: 38302488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database.
    Chen B; Zhang X; Liu Y; Wang C
    Medicine (Baltimore); 2023 Mar; 102(13):e33416. PubMed ID: 37000095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
    J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
    Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
    BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
    Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
    Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Triple-Negative Breast Cancer: Differences in Clinicopathologic and Ultrasound Features Between Premenopausal and Postmenopausal Patients.
    Zhu K; Wang D; Li Z; Du G; Guo Q; Wu T; Li J
    J Ultrasound Med; 2020 May; 39(5):919-927. PubMed ID: 31737929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.